Drawing for PHARMATIQUE+

USPTO serial 50014523

PHARMATIQUE+

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
JOHNSON, BRITTANY S
Law office
TMO LAW OFFICE 126

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with PHARMATIQUE+?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Byungwoong Park

Byungwoong Park ZION IP Law PLLC1717 K St NW, #900Wahington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
005Diet capsules; Pharmaceutical preparations for preventing and treating obesity; Non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Medicinal preparations for the treatment of digestive diseases, inflammatory disorders and obesity; Vitamin and mineral supplements; Anti-inflammatory preparations; Pharmaceutical preparations for the treatment of digestive diseases; Appetite suppressants; Dietary supplemental drinks; Medicated ointments for treating dermatological conditions; Antibiotic ointments; Anti-itch ointment; Anti-inflammatory ointments; Sunburn ointments; Nutritional supplement meal replacement bars for boosting energy; Acne medications; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of digestive diseases, inflammatory disorders, obesity; Medicinal herb extracts; Ginseng for medicinal use; Ginseng capsules for medical purposes; Medicated lotions for skin protection; Nutritionally fortified beverages for medical purposes; Medicinal drinks; Medicated confectionery for the treatment of digestive diseases, inflammatory disorders, obesity; Medicinal preparations for the treatment of digestive diseases, inflammatory disorders, obesity; Dietary supplements for persons with special dietary requirements; Dietary supplements consisting primarily of red ginseng; Royal jelly for medical purposes; Royal jelly for pharmaceutical purposes; Vitamin supplements; Nutritional supplements; Dietary supplements with a cosmetic effect; Dietary supplements for humans; Multivitamin preparations; Dietary supplements consisting primarily of amino acids, minerals and trace elements; Mixed vitamin preparations; Food supplements; Medicinal creams for skin care; Plant extracts for pharmaceutical purposes'ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 2, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 2, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Nov 2, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 2, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 26, 2026DOCKASSIGNED TO EXAMINER—
Sep 24, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 24, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2026TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jul 29, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 29, 2026ALIEASSIGNED TO LIE—
Jul 28, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 28, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 27, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 27, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance